Last edition
News about "Karo Healthcare"
Moberg Pharma Secures US Patent for Improved MOB-015 Dosing Regimen
Moberg Pharma secures US patent for an improved dosing regimen of MOB-015, strengthening its intellectual property portfolio through December 2041.
Karo Healthcare | 04/11/2026 | By News Bureau
Moberg Pharma AB has entered into an exclusive licensing agreement with Karo Healthcare AB for the commercialization of MOB-015 (Terclara) in 19 European markets.
Karo Healthcare | 06/11/2025 | By Darshana | 401
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy